Please login to the form below

Not currently logged in

Excellence in Demonstrating Economic and Societal Value (New for 2017)

Back to categories

Judging Criteria:

Excellence in creating market and customer insight

  • Demonstrate how you gained in-depth understanding of the health economic and social  value that might be created

Clarity and appropriateness of objectives

  • Demonstrate how your objectives related to all stakeholders and reinforced each other

Quality of strategy development based on insights

  • Evidence of resource allocation decisions designed to demonstrate health economic and social value
  • Evidence of choices not to allocate resources

Quality of execution

  • Evidence as to methods and tactics were based on the strategy
  • Evidence as to how methods and tactics reinforced each other
  • Evidence of organisational changes made to support strategy execution
  • Evidence of working with other stakeholders to support strategy execution

Quality of measurement and learning  

  • Demonstrate how metrics have been applied to measure outcomes
  • Evidence of knowledge gained that will inform and shape future decision-making

Evidence of value demonstration

  • Evidence of demonstrated health economic value
  • Evidence of demonstrated social value
  • Evidence of other demonstrated
  • Evidence of changes in customer or patient behaviour as a result of value demonstration.

This award recognises excellence in work, conducted by any organisation involved in any market, whose aim was to demonstrate the health economic or social value of any treatment. These include, but are not restricted to:

  • Demonstration of value arising from clinically efficacy of a product
  • Demonstration of value arising from ease of use or patient compliance
  • Demonstration of value arising from pricing structures and agreements
  • Demonstration of value arising from support and services associated with the product
  • Demonstration of value arising from more appropriate prescribing.

Entries are invited from any individual, team, service or organisation that has demonstrated economic or societal  value, by whatever means and from whatever sources. Judges will be looking for evidence of impact, sustainability and innovation.

Potential entrants might include:

  • UK, European or international pharmaceutical, biotech, ethical, life science, OTC and medical   device/diagnostic companies who are working in emerging or global markets
  • Healthcare agencies and consultancies.

Work conducted up to and including December 2016 will be eligible.


Back to categories